CURRENT ISSUES IN THROMBOSIS PREVENTION WITH ANTIPLATELET DRUGS

被引：28

作者：

DEGAETANO, G ^{[1
]}

CERLETTI, C ^{[1
]}

DEJANA, E ^{[1
]}

VERMYLEN, J ^{[1
]}

机构：

[1] CATHOLIC UNIV LEUVEN, CTR THROMBOSIS & VASC RES, B-3000 LOUVAIN, BELGIUM

来源：

DRUGS | 1986年 / 31卷 / 06期

关键词：

D O I：

10.2165/00003495-198631060-00004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：517 / 549

页数：33

共 255 条

[11] ANTITHROMBOTIC THERAPY IN CORONARY-ARTERY DISEASE [J].

BERTELE, V ;

SALZMAN, EW .

ARTERIOSCLEROSIS, 1985, 5 (02) :119-134

[12]

BERTELE V, 1981, LANCET, V1, P1057

[13]

BERTELE V, 1984, BLOOD, V63, P1460

[14] PLATELET THROMBOXANE SYNTHETASE INHIBITORS WITH LOW-DOSES OF ASPIRIN - POSSIBLE RESOLUTION OF THE ASPIRIN DILEMMA [J].

BERTELE, V ;

FALANGA, A ;

TOMASIAK, M ;

DEJANA, E ;

CERLETTI, C ;

DEGAETANO, G .

SCIENCE, 1983, 220 (4596) :517-519

[15] INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].

BEVILACQUA, MP ;

POBER, JS ;

MAJEAU, GR ;

COTRAN, RS ;

GIMBRONE, MA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623

[16]

BIERME R, 1972, LANCET, V1, P432

[17] THE BIOLOGIC BACKGROUND TO SOME THERAPEUTIC USES OF ASPIRIN [J].

BORN, GVR ;

GOROG, P ;

BEGENT, NA .

AMERICAN JOURNAL OF MEDICINE, 1983, 74 (6A) :2-9

[18]

BORN GVR, 1981, INTERACTIONS PLATELE

[19]

Bornstein P, 1982, PATHOBIOLOGY ENDOTHE, V6, P215, DOI [DOI 10.1016/B978-0-12-521980-8.50020-1, 10.1016/B978-0-12-521980-8.50020-1]

[20] PROLONGATION OF BLEEDING-TIME AND INHIBITION OF PLATELET-AGGREGATION BY LOW-DOSE ACETYLSALICYLIC-ACID IN PATIENTS WITH CEREBROVASCULAR-DISEASE [J].

BOYSEN, G ;

BOSS, AH ;

ODUM, N ;

OLSEN, JS .

STROKE, 1984, 15 (02) :241-243

← 1 2 3 4 5 6 7 8 9 10 →